Similar articles

• Anti-oxidants and coronary heart disease.

  Ubbink JB, Vermaak WJ. Ubbink JB, et al. S Afr Med J. 1995 Dec;85(12):1279-81. S Afr Med J. 1995. PMID: 8600584 Review. No abstract available.
• Oxidised low density lipoprotein, antioxidants and coronary atherosclerosis.

  Gambhir DS, Gambhir JK. Gambhir DS, et al. Indian Heart J. 1997 Jan-Feb;49(1):19-22. Indian Heart J. 1997. PMID: 9130420 Review. No abstract available.
• Interleukin-10 correlates with oxidized low density lipoprotein in coronary culprit plaques.

  Nishihira K, Imamura T, Ishikawa T, Yamashita A, Shibata Y, Itabe H, Kitamura K, Asada Y. Nishihira K, et al. Thromb Res. 2009 Jul;124(3):335-7. doi: 10.1016/j.thromres.2009.02.005. Epub 2009 Mar 9. Thromb Res. 2009. PMID: 19272636 No abstract available.
• Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.

  Yu P, Xiong T, Tenedero CB, Lebeau P, Ni R, MacDonald ME, Gross PL, Austin RC, Trigatti BL. Yu P, et al. Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):26-39. doi: 10.1161/ATVBAHA.117.305140. Epub 2017 Nov 21. Arterioscler Thromb Vasc Biol. 2018. PMID: 29162602 Free PMC article.
• [Current views on lowering blood cholesterol for prevention of coronary artery diseases].

  Zhao S. Zhao S. Zhonghua Nei Ke Za Zhi. 2001 May;40(5):290-2. Zhonghua Nei Ke Za Zhi. 2001. PMID: 12947967 Chinese. No abstract available.